User login
AGA’s GI Opportunity Fund invests in EndoSound®
EndoSound is an Oregon-based medical device innovator developing technology that enhances access, reduces costs, and increases the safety of endoscopic ultrasound (EUS) procedures.
The EndoSound Vision System® (EVS®) is a disruptive EUS platform. Its attachable transducer and supportive components transform a conventional upper endoscope into a fully functional endoscopic ultrasound device. The cost of existing EUS systems has limited the availability of this crucial modality in the United States and around the world.
By reducing this cost, the EVS will provide physicians with a technological option that can enable care for their patients in a greater number of locations and settings. This brings the potential for enormous benefits to patients, payers, and providers by reducing costs in the healthcare system.
EndoSound is an Oregon-based medical device innovator developing technology that enhances access, reduces costs, and increases the safety of endoscopic ultrasound (EUS) procedures.
The EndoSound Vision System® (EVS®) is a disruptive EUS platform. Its attachable transducer and supportive components transform a conventional upper endoscope into a fully functional endoscopic ultrasound device. The cost of existing EUS systems has limited the availability of this crucial modality in the United States and around the world.
By reducing this cost, the EVS will provide physicians with a technological option that can enable care for their patients in a greater number of locations and settings. This brings the potential for enormous benefits to patients, payers, and providers by reducing costs in the healthcare system.
EndoSound is an Oregon-based medical device innovator developing technology that enhances access, reduces costs, and increases the safety of endoscopic ultrasound (EUS) procedures.
The EndoSound Vision System® (EVS®) is a disruptive EUS platform. Its attachable transducer and supportive components transform a conventional upper endoscope into a fully functional endoscopic ultrasound device. The cost of existing EUS systems has limited the availability of this crucial modality in the United States and around the world.
By reducing this cost, the EVS will provide physicians with a technological option that can enable care for their patients in a greater number of locations and settings. This brings the potential for enormous benefits to patients, payers, and providers by reducing costs in the healthcare system.
A special tribute: Memorial and honorary gifts
Did you know you can honor a family member, friend, or colleague through a gift to the AGA Research Foundation?
- Giving now or later. Any charitable gift can be made in honor or memory of someone.
- A gift today. An outright gift will help fund the AGA Research Awards Program. Your gift will assist in furthering basic digestive disease research, which can ultimately advance research into all digestive diseases. The financial benefits include an income tax deduction and possible elimination of capital gains tax.
- A gift through your will or living trust. You can include a bequest in your will or living trust stating that a specific asset, certain dollar amount, or more commonly a percentage of your estate will pass to the AGA Research Foundation at your death in honor of your loved one.
- Named opportunities. Individuals interested in receiving name recognition for a listed AGA Institute program can do so by contributing a new, unrestricted gift to the AGA Research Foundation. The gift can be payable over five years. Endowed opportunities are also available.
Your next step
An honorary gift is a wonderful way to acknowledge someone’s vision for the future. To learn more about ways to recognize your honoree, visit our website.
Did you know you can honor a family member, friend, or colleague through a gift to the AGA Research Foundation?
- Giving now or later. Any charitable gift can be made in honor or memory of someone.
- A gift today. An outright gift will help fund the AGA Research Awards Program. Your gift will assist in furthering basic digestive disease research, which can ultimately advance research into all digestive diseases. The financial benefits include an income tax deduction and possible elimination of capital gains tax.
- A gift through your will or living trust. You can include a bequest in your will or living trust stating that a specific asset, certain dollar amount, or more commonly a percentage of your estate will pass to the AGA Research Foundation at your death in honor of your loved one.
- Named opportunities. Individuals interested in receiving name recognition for a listed AGA Institute program can do so by contributing a new, unrestricted gift to the AGA Research Foundation. The gift can be payable over five years. Endowed opportunities are also available.
Your next step
An honorary gift is a wonderful way to acknowledge someone’s vision for the future. To learn more about ways to recognize your honoree, visit our website.
Did you know you can honor a family member, friend, or colleague through a gift to the AGA Research Foundation?
- Giving now or later. Any charitable gift can be made in honor or memory of someone.
- A gift today. An outright gift will help fund the AGA Research Awards Program. Your gift will assist in furthering basic digestive disease research, which can ultimately advance research into all digestive diseases. The financial benefits include an income tax deduction and possible elimination of capital gains tax.
- A gift through your will or living trust. You can include a bequest in your will or living trust stating that a specific asset, certain dollar amount, or more commonly a percentage of your estate will pass to the AGA Research Foundation at your death in honor of your loved one.
- Named opportunities. Individuals interested in receiving name recognition for a listed AGA Institute program can do so by contributing a new, unrestricted gift to the AGA Research Foundation. The gift can be payable over five years. Endowed opportunities are also available.
Your next step
An honorary gift is a wonderful way to acknowledge someone’s vision for the future. To learn more about ways to recognize your honoree, visit our website.
What the omnibus bill means for GI
Here’s what you need to know:
Medicare payment cuts
Unfortunately, physicians treating Medicare patients will face cuts in the new year.
It is disappointing that Congress failed to stop the full cuts. However, the Medicare payment cuts will be lower than the initially proposed 8.5% cut. Physicians will face a 2% cut because of the 4% in PAYGO relief for 2023 and 2024, plus an additional 2.5% in relief for the Centers for Medicare & Medicaid Services.
This is not an ideal outcome, but we are grateful to the more than 160 AGA members who raised their voices and sent over 600 messages to Congress. Your advocacy played a role in alleviating the final number of the cuts.
We will continue to urge Congress to stop the full cuts. Our top priority in 2023 remains addressing the Medicare reimbursement rates.
Two-year extension for telehealth
Good news! We have been ongoing supporters of telehealth expansion that resulted from the COVID-19 pandemic. The inclusion of this 2-year telehealth extension will allow doctors to continue to treat Medicare patients in a virtual setting. This is crucial since it allows patients to continue receiving treatment from their doctor in a virtual setting, and it provides patients and providers with certainty.
$2.5 billion increase for NIH
Good news! The omnibus allocates $47.5 billion for the National Institutes of Health’s budget, a $2.5 billion increase from 2023. The increased federal research funding is something we advocated for with congressional offices during Advocacy Day and will support GI researchers who are conducting innovative research and developing treatment for digestive diseases and GI cancers.
AGA-submitted report language on IBD included
Good news! Two language requests submitted by AGA on inflammatory bowel disease (IBD) were included in the omnibus: one in the 2023 Department of Labor, Health and Human Services, Education and Related Agencies funding bill and one in the 2023 Department of Agriculture, Rural Development, Food and Drug Administration and Related Agencies funding bill.
The first reaffirms the Appropriations Committee’s support for the NIH in funding basic, translational, and clinical studies on the diagnosis and treatment of IBD. The second encourages the FDA to improve diversity and patient-centricity in IBD clinical trials. The inclusion of these language requests in the omnibus highlights another successful advocacy effort by AGA.
Here’s what you need to know:
Medicare payment cuts
Unfortunately, physicians treating Medicare patients will face cuts in the new year.
It is disappointing that Congress failed to stop the full cuts. However, the Medicare payment cuts will be lower than the initially proposed 8.5% cut. Physicians will face a 2% cut because of the 4% in PAYGO relief for 2023 and 2024, plus an additional 2.5% in relief for the Centers for Medicare & Medicaid Services.
This is not an ideal outcome, but we are grateful to the more than 160 AGA members who raised their voices and sent over 600 messages to Congress. Your advocacy played a role in alleviating the final number of the cuts.
We will continue to urge Congress to stop the full cuts. Our top priority in 2023 remains addressing the Medicare reimbursement rates.
Two-year extension for telehealth
Good news! We have been ongoing supporters of telehealth expansion that resulted from the COVID-19 pandemic. The inclusion of this 2-year telehealth extension will allow doctors to continue to treat Medicare patients in a virtual setting. This is crucial since it allows patients to continue receiving treatment from their doctor in a virtual setting, and it provides patients and providers with certainty.
$2.5 billion increase for NIH
Good news! The omnibus allocates $47.5 billion for the National Institutes of Health’s budget, a $2.5 billion increase from 2023. The increased federal research funding is something we advocated for with congressional offices during Advocacy Day and will support GI researchers who are conducting innovative research and developing treatment for digestive diseases and GI cancers.
AGA-submitted report language on IBD included
Good news! Two language requests submitted by AGA on inflammatory bowel disease (IBD) were included in the omnibus: one in the 2023 Department of Labor, Health and Human Services, Education and Related Agencies funding bill and one in the 2023 Department of Agriculture, Rural Development, Food and Drug Administration and Related Agencies funding bill.
The first reaffirms the Appropriations Committee’s support for the NIH in funding basic, translational, and clinical studies on the diagnosis and treatment of IBD. The second encourages the FDA to improve diversity and patient-centricity in IBD clinical trials. The inclusion of these language requests in the omnibus highlights another successful advocacy effort by AGA.
Here’s what you need to know:
Medicare payment cuts
Unfortunately, physicians treating Medicare patients will face cuts in the new year.
It is disappointing that Congress failed to stop the full cuts. However, the Medicare payment cuts will be lower than the initially proposed 8.5% cut. Physicians will face a 2% cut because of the 4% in PAYGO relief for 2023 and 2024, plus an additional 2.5% in relief for the Centers for Medicare & Medicaid Services.
This is not an ideal outcome, but we are grateful to the more than 160 AGA members who raised their voices and sent over 600 messages to Congress. Your advocacy played a role in alleviating the final number of the cuts.
We will continue to urge Congress to stop the full cuts. Our top priority in 2023 remains addressing the Medicare reimbursement rates.
Two-year extension for telehealth
Good news! We have been ongoing supporters of telehealth expansion that resulted from the COVID-19 pandemic. The inclusion of this 2-year telehealth extension will allow doctors to continue to treat Medicare patients in a virtual setting. This is crucial since it allows patients to continue receiving treatment from their doctor in a virtual setting, and it provides patients and providers with certainty.
$2.5 billion increase for NIH
Good news! The omnibus allocates $47.5 billion for the National Institutes of Health’s budget, a $2.5 billion increase from 2023. The increased federal research funding is something we advocated for with congressional offices during Advocacy Day and will support GI researchers who are conducting innovative research and developing treatment for digestive diseases and GI cancers.
AGA-submitted report language on IBD included
Good news! Two language requests submitted by AGA on inflammatory bowel disease (IBD) were included in the omnibus: one in the 2023 Department of Labor, Health and Human Services, Education and Related Agencies funding bill and one in the 2023 Department of Agriculture, Rural Development, Food and Drug Administration and Related Agencies funding bill.
The first reaffirms the Appropriations Committee’s support for the NIH in funding basic, translational, and clinical studies on the diagnosis and treatment of IBD. The second encourages the FDA to improve diversity and patient-centricity in IBD clinical trials. The inclusion of these language requests in the omnibus highlights another successful advocacy effort by AGA.
CHEST simulation courses support learning for every career stage
One mark of an excellent clinician is their commitment to lifelong learning, and CHEST’s hands-on simulation courses offer the chance for practitioners of all experience levels to enhance their knowledge.
A variety of interactive courses are offered at CHEST’s state-of-the-art Innovation, Simulation, and Training Center in Glenview, Illinois, covering topics like ultrasonography, bronchoscopy, and mechanical ventilation. And this year, our simulation schedule will offer several new sessions on advances in invasive and noninvasive ventilation, critical care transesophageal echocardiography, master-level EBUS practice, and mechanical circulatory support.
Each course is led by expert instructors and includes attendees from a full range of career stages, from trainees and mid-career clinicians to long-time CHEST faculty members.
At a fall 2022 session of the Ultrasonography: Essentials in Critical Care course, Adil Ahmed, MD, an intern at the University of Texas Health Science Center at San Antonio, shared his perspective attending as a resident.
“CHEST has lots of specialized resources and renowned faculty members, and they’re doing an exceptional job,” he said. “A lot of the things I’ve learned in the first workshop alone are completely brand new to me. I think more programs should start sending residents to these courses.”
Trainees don’t just attend simulation courses – they teach them, too. Carmen Mei, MD, a pulmonary and critical care fellow at Rutgers University, was a faculty member at the recent ultrasound course. She taught attendees representing a wide array of ages.
“It’s a learning environment. Everybody’s very engaged, no matter where they are in their career,” she said.
As a mid-career clinician, Yonatan Y. Greenstein, MD, FCCP – who serves as a co-chair of the ultrasonography course – appreciates the diversity of experiences among attendees.
“Over the years, we’ve found that the wide breadth enhances the course because learners appreciate the questions that are brought up from different angles,” he said.
For experienced clinicians like CHEST Immediate Past President David Schulman, MD, MPH, FCCP, the interactive courses provide an opportunity to continue expanding his expertise. At the ultrasound course, Dr. Schulman said he enjoyed the chance to extend and refine his skillset alongside clinicians with a broad range of experience levels.
“Ultrasound is one of those skills that many clinicians, even in their forties and older, have never trained in. It’s great to see how the more junior learners approach this with a very excited mindset, and they’re learning right beside mid-career faculty who didn’t have the exposure to ultrasound when they were young,” he said.
To find the simulation course that’s the best fit for your practice, visit chestnet.org/simulation.
One mark of an excellent clinician is their commitment to lifelong learning, and CHEST’s hands-on simulation courses offer the chance for practitioners of all experience levels to enhance their knowledge.
A variety of interactive courses are offered at CHEST’s state-of-the-art Innovation, Simulation, and Training Center in Glenview, Illinois, covering topics like ultrasonography, bronchoscopy, and mechanical ventilation. And this year, our simulation schedule will offer several new sessions on advances in invasive and noninvasive ventilation, critical care transesophageal echocardiography, master-level EBUS practice, and mechanical circulatory support.
Each course is led by expert instructors and includes attendees from a full range of career stages, from trainees and mid-career clinicians to long-time CHEST faculty members.
At a fall 2022 session of the Ultrasonography: Essentials in Critical Care course, Adil Ahmed, MD, an intern at the University of Texas Health Science Center at San Antonio, shared his perspective attending as a resident.
“CHEST has lots of specialized resources and renowned faculty members, and they’re doing an exceptional job,” he said. “A lot of the things I’ve learned in the first workshop alone are completely brand new to me. I think more programs should start sending residents to these courses.”
Trainees don’t just attend simulation courses – they teach them, too. Carmen Mei, MD, a pulmonary and critical care fellow at Rutgers University, was a faculty member at the recent ultrasound course. She taught attendees representing a wide array of ages.
“It’s a learning environment. Everybody’s very engaged, no matter where they are in their career,” she said.
As a mid-career clinician, Yonatan Y. Greenstein, MD, FCCP – who serves as a co-chair of the ultrasonography course – appreciates the diversity of experiences among attendees.
“Over the years, we’ve found that the wide breadth enhances the course because learners appreciate the questions that are brought up from different angles,” he said.
For experienced clinicians like CHEST Immediate Past President David Schulman, MD, MPH, FCCP, the interactive courses provide an opportunity to continue expanding his expertise. At the ultrasound course, Dr. Schulman said he enjoyed the chance to extend and refine his skillset alongside clinicians with a broad range of experience levels.
“Ultrasound is one of those skills that many clinicians, even in their forties and older, have never trained in. It’s great to see how the more junior learners approach this with a very excited mindset, and they’re learning right beside mid-career faculty who didn’t have the exposure to ultrasound when they were young,” he said.
To find the simulation course that’s the best fit for your practice, visit chestnet.org/simulation.
One mark of an excellent clinician is their commitment to lifelong learning, and CHEST’s hands-on simulation courses offer the chance for practitioners of all experience levels to enhance their knowledge.
A variety of interactive courses are offered at CHEST’s state-of-the-art Innovation, Simulation, and Training Center in Glenview, Illinois, covering topics like ultrasonography, bronchoscopy, and mechanical ventilation. And this year, our simulation schedule will offer several new sessions on advances in invasive and noninvasive ventilation, critical care transesophageal echocardiography, master-level EBUS practice, and mechanical circulatory support.
Each course is led by expert instructors and includes attendees from a full range of career stages, from trainees and mid-career clinicians to long-time CHEST faculty members.
At a fall 2022 session of the Ultrasonography: Essentials in Critical Care course, Adil Ahmed, MD, an intern at the University of Texas Health Science Center at San Antonio, shared his perspective attending as a resident.
“CHEST has lots of specialized resources and renowned faculty members, and they’re doing an exceptional job,” he said. “A lot of the things I’ve learned in the first workshop alone are completely brand new to me. I think more programs should start sending residents to these courses.”
Trainees don’t just attend simulation courses – they teach them, too. Carmen Mei, MD, a pulmonary and critical care fellow at Rutgers University, was a faculty member at the recent ultrasound course. She taught attendees representing a wide array of ages.
“It’s a learning environment. Everybody’s very engaged, no matter where they are in their career,” she said.
As a mid-career clinician, Yonatan Y. Greenstein, MD, FCCP – who serves as a co-chair of the ultrasonography course – appreciates the diversity of experiences among attendees.
“Over the years, we’ve found that the wide breadth enhances the course because learners appreciate the questions that are brought up from different angles,” he said.
For experienced clinicians like CHEST Immediate Past President David Schulman, MD, MPH, FCCP, the interactive courses provide an opportunity to continue expanding his expertise. At the ultrasound course, Dr. Schulman said he enjoyed the chance to extend and refine his skillset alongside clinicians with a broad range of experience levels.
“Ultrasound is one of those skills that many clinicians, even in their forties and older, have never trained in. It’s great to see how the more junior learners approach this with a very excited mindset, and they’re learning right beside mid-career faculty who didn’t have the exposure to ultrasound when they were young,” he said.
To find the simulation course that’s the best fit for your practice, visit chestnet.org/simulation.
CHEST President shares inside look at priorities, plans for 2023
Attendees at the CHEST 2022 Opening Session on October 16 got a sneak peek into plans and priorities for CHEST President Doreen J. Addrizzo-Harris, MD, FCCP, in 2023 – and some insights into her own path to the role.
A longtime leader at CHEST, she shared how members’ pandemic response reminded her of the great impact the organization can have. In March 2020, Dr. Addrizzo-Harris was overseeing ICU staffing at NYU Langone Health’s Bellevue Hospital Center and organizing dozens of volunteer physicians to help meet the pandemic care burden.
“I knew all too quickly that we wouldn’t have enough intensivists,” said Dr. Addrizzo-Harris. “It was a quick call very late one night, probably around 1 am, that I made to CHEST CEO, Bob Musacchio, that helped materialize a monumental effort ... many of these physicians were CHEST members themselves. They were fearless and unselfish, and they came to help us in our time of need.”
She saw this same spirit of dedication and drive in CHEST’s leadership and staff, she said – one she will continue and expand upon during her presidency.
“I’ve watched our last three presidents lead by great example ... with innovation and nimbleness, in a time when we were so isolated from each other and so tired from the long hours that we worked each day,” she said. “They, along with the Board of Regents, the CEO, and our phenomenal staff, were able to keep CHEST amazingly alive and vibrant and more connected than ever. They are truly inspiring. For 2023, I hope to take this incredible energy to the next level.”
As CHEST president, Dr. in the United States and advancing international outreach initiatives launched by CHEST Past President David Schulman, MD, MPH, FCCP. This also includes supporting and building upon CHEST’s ongoing commitment to diversity, equity, and inclusion initiatives to encourage greater representation in the field and improve patient care.
“Whether it’s through supporting our clinical research grants, expanding patient education and advocacy, or programs like the First 5 Minutes™ and the Harold Amos scholarship program, we want to train our leaders for the future,” she said.
Revisit the September issue of CHEST Physician, and watch future issues to learn more about Dr. Addrizzo-Harris and her plans for the presidency.
Attendees at the CHEST 2022 Opening Session on October 16 got a sneak peek into plans and priorities for CHEST President Doreen J. Addrizzo-Harris, MD, FCCP, in 2023 – and some insights into her own path to the role.
A longtime leader at CHEST, she shared how members’ pandemic response reminded her of the great impact the organization can have. In March 2020, Dr. Addrizzo-Harris was overseeing ICU staffing at NYU Langone Health’s Bellevue Hospital Center and organizing dozens of volunteer physicians to help meet the pandemic care burden.
“I knew all too quickly that we wouldn’t have enough intensivists,” said Dr. Addrizzo-Harris. “It was a quick call very late one night, probably around 1 am, that I made to CHEST CEO, Bob Musacchio, that helped materialize a monumental effort ... many of these physicians were CHEST members themselves. They were fearless and unselfish, and they came to help us in our time of need.”
She saw this same spirit of dedication and drive in CHEST’s leadership and staff, she said – one she will continue and expand upon during her presidency.
“I’ve watched our last three presidents lead by great example ... with innovation and nimbleness, in a time when we were so isolated from each other and so tired from the long hours that we worked each day,” she said. “They, along with the Board of Regents, the CEO, and our phenomenal staff, were able to keep CHEST amazingly alive and vibrant and more connected than ever. They are truly inspiring. For 2023, I hope to take this incredible energy to the next level.”
As CHEST president, Dr. in the United States and advancing international outreach initiatives launched by CHEST Past President David Schulman, MD, MPH, FCCP. This also includes supporting and building upon CHEST’s ongoing commitment to diversity, equity, and inclusion initiatives to encourage greater representation in the field and improve patient care.
“Whether it’s through supporting our clinical research grants, expanding patient education and advocacy, or programs like the First 5 Minutes™ and the Harold Amos scholarship program, we want to train our leaders for the future,” she said.
Revisit the September issue of CHEST Physician, and watch future issues to learn more about Dr. Addrizzo-Harris and her plans for the presidency.
Attendees at the CHEST 2022 Opening Session on October 16 got a sneak peek into plans and priorities for CHEST President Doreen J. Addrizzo-Harris, MD, FCCP, in 2023 – and some insights into her own path to the role.
A longtime leader at CHEST, she shared how members’ pandemic response reminded her of the great impact the organization can have. In March 2020, Dr. Addrizzo-Harris was overseeing ICU staffing at NYU Langone Health’s Bellevue Hospital Center and organizing dozens of volunteer physicians to help meet the pandemic care burden.
“I knew all too quickly that we wouldn’t have enough intensivists,” said Dr. Addrizzo-Harris. “It was a quick call very late one night, probably around 1 am, that I made to CHEST CEO, Bob Musacchio, that helped materialize a monumental effort ... many of these physicians were CHEST members themselves. They were fearless and unselfish, and they came to help us in our time of need.”
She saw this same spirit of dedication and drive in CHEST’s leadership and staff, she said – one she will continue and expand upon during her presidency.
“I’ve watched our last three presidents lead by great example ... with innovation and nimbleness, in a time when we were so isolated from each other and so tired from the long hours that we worked each day,” she said. “They, along with the Board of Regents, the CEO, and our phenomenal staff, were able to keep CHEST amazingly alive and vibrant and more connected than ever. They are truly inspiring. For 2023, I hope to take this incredible energy to the next level.”
As CHEST president, Dr. in the United States and advancing international outreach initiatives launched by CHEST Past President David Schulman, MD, MPH, FCCP. This also includes supporting and building upon CHEST’s ongoing commitment to diversity, equity, and inclusion initiatives to encourage greater representation in the field and improve patient care.
“Whether it’s through supporting our clinical research grants, expanding patient education and advocacy, or programs like the First 5 Minutes™ and the Harold Amos scholarship program, we want to train our leaders for the future,” she said.
Revisit the September issue of CHEST Physician, and watch future issues to learn more about Dr. Addrizzo-Harris and her plans for the presidency.
CHEST 2022 award winners More award winners
Each year,
MASTER FELLOW AWARD
Gerard A. Silvestri, MD, MS, Master FCCP
DISTINGUISHED SERVICE AWARD
Aneesa M. Das, MD, FCCP
COLLEGE MEDALIST AWARD
William R. Auger, MD, FCCP
ALFRED SOFFER AWARD FOR EDITORIAL EXCELLENCE
Todd W. Rice, MD, FCCP
EARLY CAREER CLINICIAN EDUCATOR AWARD
Mauricio Danckers, MD, FCCP
MASTER CLINICIAN EDUCATOR AWARD
Neil R. MacIntyre, MD, FCCP
PRESIDENTIAL CITATION
CHEST Staff
EDWARD C. ROSENOW III, MD, MASTER FCCP/MASTER TEACHER ENDOWED HONOR LECTURE
Alexander S. Niven, MD, FCCP
THOMAS L. PETTY, MD, MASTER FCCP MEMORIAL LECTURE
Sandra G. Adams, MD, FCCP
2021 DISTINGUISHED SCIENTIST HONOR LECTURE IN CARDIOPULMONARY PHYSIOLOGY
Kenneth I. Berger, MD, FCCP
PRESIDENTIAL HONOR LECTURE
Jack D. Buckley, MD, MPH, FCCP
PASQUALE CIAGLIA MEMORIAL LECTURE IN INTERVENTIONAL MEDICINE
Nicholas J. Pastis, MD, FCCP
ROGER C. BONE MEMORIAL LECTURE IN CRITICAL CARE
E. Wesley Ely, MD, MPH, FCCP
MURRAY KORNFELD MEMORIAL FOUNDERS AWARD
Marin H. Kollef, MD, FCCP
OM P. SHARMA, MD, MASTER FCCP MEMORIAL LECTURE
Daniel A. Culver, DO, FCCP
RICHARD S. IRWIN, MD, MASTER FCCP HONOR LECTURE
Nneka O. Sederstrom, PhD, MS, MA, FCCP
2022 DISTINGUISHED SCIENTIST HONOR LECTURE IN CARDIOPULMONARY PHYSIOLOGY
Martin J. Tobin, MBBCh, FCCP
MARK J. ROSEN, MD, MASTER FCCP ENDOWED MEMORIAL LECTURE
Stephanie M. Levine, MD, FCCP
MARGARET PFROMMER ENDOWED MEMORIAL LECTURE IN HOME-BASED MECHANICAL VENTILATION
Lisa Wolfe, MD, FCCP
CHEST CHALLENGE FINALISTS
1st Place – Mayo Clinic
Amjad Kanj, MD
Paige Marty, MD
Zhenmei Zhang, MD
Program Director: Darlene Nelson, MD, FCCP
2nd Place – Brooke Army Medical Center
Joshua Boster, MD
Tyler Campbell, DO
Daniel Foster, MD
Program Director: Robert Walter, MD, PhD
3rd Place – NewYork-Presbyterian Brooklyn Methodist
Albina Guri, DO
Jahrul Islam, MD
Sylvana Salama, MD
Program Director: Anthony Saleh, MD, FCCP
Please Note: Award winners from the following categories will be listed in the February issue of CHEST Physician.
CHEST Foundation Grant Awards
Scientific Abstract Awards
Alfred Soffer Research Award Winners
Young Investigator Award Winners
Abstract Rapid Fire Winners
Case Report Session Winners
Case Report Rapid Fire Winners
Each year,
MASTER FELLOW AWARD
Gerard A. Silvestri, MD, MS, Master FCCP
DISTINGUISHED SERVICE AWARD
Aneesa M. Das, MD, FCCP
COLLEGE MEDALIST AWARD
William R. Auger, MD, FCCP
ALFRED SOFFER AWARD FOR EDITORIAL EXCELLENCE
Todd W. Rice, MD, FCCP
EARLY CAREER CLINICIAN EDUCATOR AWARD
Mauricio Danckers, MD, FCCP
MASTER CLINICIAN EDUCATOR AWARD
Neil R. MacIntyre, MD, FCCP
PRESIDENTIAL CITATION
CHEST Staff
EDWARD C. ROSENOW III, MD, MASTER FCCP/MASTER TEACHER ENDOWED HONOR LECTURE
Alexander S. Niven, MD, FCCP
THOMAS L. PETTY, MD, MASTER FCCP MEMORIAL LECTURE
Sandra G. Adams, MD, FCCP
2021 DISTINGUISHED SCIENTIST HONOR LECTURE IN CARDIOPULMONARY PHYSIOLOGY
Kenneth I. Berger, MD, FCCP
PRESIDENTIAL HONOR LECTURE
Jack D. Buckley, MD, MPH, FCCP
PASQUALE CIAGLIA MEMORIAL LECTURE IN INTERVENTIONAL MEDICINE
Nicholas J. Pastis, MD, FCCP
ROGER C. BONE MEMORIAL LECTURE IN CRITICAL CARE
E. Wesley Ely, MD, MPH, FCCP
MURRAY KORNFELD MEMORIAL FOUNDERS AWARD
Marin H. Kollef, MD, FCCP
OM P. SHARMA, MD, MASTER FCCP MEMORIAL LECTURE
Daniel A. Culver, DO, FCCP
RICHARD S. IRWIN, MD, MASTER FCCP HONOR LECTURE
Nneka O. Sederstrom, PhD, MS, MA, FCCP
2022 DISTINGUISHED SCIENTIST HONOR LECTURE IN CARDIOPULMONARY PHYSIOLOGY
Martin J. Tobin, MBBCh, FCCP
MARK J. ROSEN, MD, MASTER FCCP ENDOWED MEMORIAL LECTURE
Stephanie M. Levine, MD, FCCP
MARGARET PFROMMER ENDOWED MEMORIAL LECTURE IN HOME-BASED MECHANICAL VENTILATION
Lisa Wolfe, MD, FCCP
CHEST CHALLENGE FINALISTS
1st Place – Mayo Clinic
Amjad Kanj, MD
Paige Marty, MD
Zhenmei Zhang, MD
Program Director: Darlene Nelson, MD, FCCP
2nd Place – Brooke Army Medical Center
Joshua Boster, MD
Tyler Campbell, DO
Daniel Foster, MD
Program Director: Robert Walter, MD, PhD
3rd Place – NewYork-Presbyterian Brooklyn Methodist
Albina Guri, DO
Jahrul Islam, MD
Sylvana Salama, MD
Program Director: Anthony Saleh, MD, FCCP
Please Note: Award winners from the following categories will be listed in the February issue of CHEST Physician.
CHEST Foundation Grant Awards
Scientific Abstract Awards
Alfred Soffer Research Award Winners
Young Investigator Award Winners
Abstract Rapid Fire Winners
Case Report Session Winners
Case Report Rapid Fire Winners
Each year,
MASTER FELLOW AWARD
Gerard A. Silvestri, MD, MS, Master FCCP
DISTINGUISHED SERVICE AWARD
Aneesa M. Das, MD, FCCP
COLLEGE MEDALIST AWARD
William R. Auger, MD, FCCP
ALFRED SOFFER AWARD FOR EDITORIAL EXCELLENCE
Todd W. Rice, MD, FCCP
EARLY CAREER CLINICIAN EDUCATOR AWARD
Mauricio Danckers, MD, FCCP
MASTER CLINICIAN EDUCATOR AWARD
Neil R. MacIntyre, MD, FCCP
PRESIDENTIAL CITATION
CHEST Staff
EDWARD C. ROSENOW III, MD, MASTER FCCP/MASTER TEACHER ENDOWED HONOR LECTURE
Alexander S. Niven, MD, FCCP
THOMAS L. PETTY, MD, MASTER FCCP MEMORIAL LECTURE
Sandra G. Adams, MD, FCCP
2021 DISTINGUISHED SCIENTIST HONOR LECTURE IN CARDIOPULMONARY PHYSIOLOGY
Kenneth I. Berger, MD, FCCP
PRESIDENTIAL HONOR LECTURE
Jack D. Buckley, MD, MPH, FCCP
PASQUALE CIAGLIA MEMORIAL LECTURE IN INTERVENTIONAL MEDICINE
Nicholas J. Pastis, MD, FCCP
ROGER C. BONE MEMORIAL LECTURE IN CRITICAL CARE
E. Wesley Ely, MD, MPH, FCCP
MURRAY KORNFELD MEMORIAL FOUNDERS AWARD
Marin H. Kollef, MD, FCCP
OM P. SHARMA, MD, MASTER FCCP MEMORIAL LECTURE
Daniel A. Culver, DO, FCCP
RICHARD S. IRWIN, MD, MASTER FCCP HONOR LECTURE
Nneka O. Sederstrom, PhD, MS, MA, FCCP
2022 DISTINGUISHED SCIENTIST HONOR LECTURE IN CARDIOPULMONARY PHYSIOLOGY
Martin J. Tobin, MBBCh, FCCP
MARK J. ROSEN, MD, MASTER FCCP ENDOWED MEMORIAL LECTURE
Stephanie M. Levine, MD, FCCP
MARGARET PFROMMER ENDOWED MEMORIAL LECTURE IN HOME-BASED MECHANICAL VENTILATION
Lisa Wolfe, MD, FCCP
CHEST CHALLENGE FINALISTS
1st Place – Mayo Clinic
Amjad Kanj, MD
Paige Marty, MD
Zhenmei Zhang, MD
Program Director: Darlene Nelson, MD, FCCP
2nd Place – Brooke Army Medical Center
Joshua Boster, MD
Tyler Campbell, DO
Daniel Foster, MD
Program Director: Robert Walter, MD, PhD
3rd Place – NewYork-Presbyterian Brooklyn Methodist
Albina Guri, DO
Jahrul Islam, MD
Sylvana Salama, MD
Program Director: Anthony Saleh, MD, FCCP
Please Note: Award winners from the following categories will be listed in the February issue of CHEST Physician.
CHEST Foundation Grant Awards
Scientific Abstract Awards
Alfred Soffer Research Award Winners
Young Investigator Award Winners
Abstract Rapid Fire Winners
Case Report Session Winners
Case Report Rapid Fire Winners
CHEST Challenge returned to the stage in the Music City
After several years of virtual competitions, the CHEST Challenge Championship returned to the stage at CHEST 2022 in Nashville, where outstanding fellows from Brooke Army Medical Center, Mayo Clinic, and NewYork-Presbyterian Brooklyn Methodist battled to compete in unconventional skills challenges and clinical trivia.
After an excellent showing from all three institutions, (not to mention, the ultimate bragging rights and the chance to raise the coveted Rosen Cup). Runner-up Brooke Army Medical Center received $3,000, and NewYork-Presbyterian Brooklyn Methodist received $1,000.
This year’s Jeopardy-style championship included a variety of category types, including everything from straightforward clinical answers in “Asthmalogic” about asthma-related issues and “Under a Microscope” for topics related to histopathology, to brain-boggling alternate options, such as “Rhyme Time,” which twisted answers in rhyming phrases.
The competition also included timed skills challenges that tested the competitors physically – and presented some very special guests.
In “Bugs and Drugs,” Team Methodist sprinted to grab and then matched unlabeled pathogen photographs with their appropriate therapeutic agents in less than 35 seconds. In another, Team Brooke aced the challenge of performing timed procedures on three different body parts in Dr. Frankenstein’s laboratory, while the monster himself (played by Board of Regents member Victor J. Test, MD, FCCP) worked to distract them.
Mayo Clinic was already in the lead by the time the Final Challenge wager was presented by William Kelly, MD, FCCP, so the team responded to the answer “This disease is inherited as an autosomal recessive trait and is a variant in the SCL34A2 gene” with their own unique reply: “Thank you, CHEST,” and a symbolic wager of $22.
Drs. Kanj, Marty, and Zhang credited their success to their training program back home, as well as the support of friends and colleagues on-site, including Program Director, Darlene Nelson, MD, FCCP. The team also prepared with mock sessions days before the championship and had a strong fan base cheering them on in the audience.
Want to join rising stars in pulmonary, critical care, and sleep medicine for next year’s championship in Hawai’i? Watch CHEST’s social media in the spring for the first phase of CHEST Challenge.
After several years of virtual competitions, the CHEST Challenge Championship returned to the stage at CHEST 2022 in Nashville, where outstanding fellows from Brooke Army Medical Center, Mayo Clinic, and NewYork-Presbyterian Brooklyn Methodist battled to compete in unconventional skills challenges and clinical trivia.
After an excellent showing from all three institutions, (not to mention, the ultimate bragging rights and the chance to raise the coveted Rosen Cup). Runner-up Brooke Army Medical Center received $3,000, and NewYork-Presbyterian Brooklyn Methodist received $1,000.
This year’s Jeopardy-style championship included a variety of category types, including everything from straightforward clinical answers in “Asthmalogic” about asthma-related issues and “Under a Microscope” for topics related to histopathology, to brain-boggling alternate options, such as “Rhyme Time,” which twisted answers in rhyming phrases.
The competition also included timed skills challenges that tested the competitors physically – and presented some very special guests.
In “Bugs and Drugs,” Team Methodist sprinted to grab and then matched unlabeled pathogen photographs with their appropriate therapeutic agents in less than 35 seconds. In another, Team Brooke aced the challenge of performing timed procedures on three different body parts in Dr. Frankenstein’s laboratory, while the monster himself (played by Board of Regents member Victor J. Test, MD, FCCP) worked to distract them.
Mayo Clinic was already in the lead by the time the Final Challenge wager was presented by William Kelly, MD, FCCP, so the team responded to the answer “This disease is inherited as an autosomal recessive trait and is a variant in the SCL34A2 gene” with their own unique reply: “Thank you, CHEST,” and a symbolic wager of $22.
Drs. Kanj, Marty, and Zhang credited their success to their training program back home, as well as the support of friends and colleagues on-site, including Program Director, Darlene Nelson, MD, FCCP. The team also prepared with mock sessions days before the championship and had a strong fan base cheering them on in the audience.
Want to join rising stars in pulmonary, critical care, and sleep medicine for next year’s championship in Hawai’i? Watch CHEST’s social media in the spring for the first phase of CHEST Challenge.
After several years of virtual competitions, the CHEST Challenge Championship returned to the stage at CHEST 2022 in Nashville, where outstanding fellows from Brooke Army Medical Center, Mayo Clinic, and NewYork-Presbyterian Brooklyn Methodist battled to compete in unconventional skills challenges and clinical trivia.
After an excellent showing from all three institutions, (not to mention, the ultimate bragging rights and the chance to raise the coveted Rosen Cup). Runner-up Brooke Army Medical Center received $3,000, and NewYork-Presbyterian Brooklyn Methodist received $1,000.
This year’s Jeopardy-style championship included a variety of category types, including everything from straightforward clinical answers in “Asthmalogic” about asthma-related issues and “Under a Microscope” for topics related to histopathology, to brain-boggling alternate options, such as “Rhyme Time,” which twisted answers in rhyming phrases.
The competition also included timed skills challenges that tested the competitors physically – and presented some very special guests.
In “Bugs and Drugs,” Team Methodist sprinted to grab and then matched unlabeled pathogen photographs with their appropriate therapeutic agents in less than 35 seconds. In another, Team Brooke aced the challenge of performing timed procedures on three different body parts in Dr. Frankenstein’s laboratory, while the monster himself (played by Board of Regents member Victor J. Test, MD, FCCP) worked to distract them.
Mayo Clinic was already in the lead by the time the Final Challenge wager was presented by William Kelly, MD, FCCP, so the team responded to the answer “This disease is inherited as an autosomal recessive trait and is a variant in the SCL34A2 gene” with their own unique reply: “Thank you, CHEST,” and a symbolic wager of $22.
Drs. Kanj, Marty, and Zhang credited their success to their training program back home, as well as the support of friends and colleagues on-site, including Program Director, Darlene Nelson, MD, FCCP. The team also prepared with mock sessions days before the championship and had a strong fan base cheering them on in the audience.
Want to join rising stars in pulmonary, critical care, and sleep medicine for next year’s championship in Hawai’i? Watch CHEST’s social media in the spring for the first phase of CHEST Challenge.
Fast facts about gifts in a will and planned giving
Gifts to charitable organizations, such as the AGA Research Foundation, in your future plans ensure your support for our mission to fund young investigators continues even after your lifetime.
#1. Wills are not for older adults only.
Having a plan for the future is important – no matter your age. A will makes your wishes known and provides your loved ones with peace of mind.
#2. Planned gifts are not complicated or confusing.
They don’t have to be. There are many types of planned gifts: Most are simple and affordable, like a gift in your will or living trust. You just need to find the one that best meets your needs.
#3. Planned gifts are not for the wealthy only.
Anyone can make a planned gift. Gifts of all sizes make a difference at the AGA Research Foundation. In fact, you may even be able to make a bigger impact than you thought possible when you make a planned gift.
For 2023, consider including a gift to the AGA Research Foundation in your will. You will help support researchers and help spark future discoveries in GI.
Want to learn more about including a gift to the AGA Research Foundation in your future plans? Visit our website at https://gastro.planmylegacy.org or contact us at [email protected].
Gifts to charitable organizations, such as the AGA Research Foundation, in your future plans ensure your support for our mission to fund young investigators continues even after your lifetime.
#1. Wills are not for older adults only.
Having a plan for the future is important – no matter your age. A will makes your wishes known and provides your loved ones with peace of mind.
#2. Planned gifts are not complicated or confusing.
They don’t have to be. There are many types of planned gifts: Most are simple and affordable, like a gift in your will or living trust. You just need to find the one that best meets your needs.
#3. Planned gifts are not for the wealthy only.
Anyone can make a planned gift. Gifts of all sizes make a difference at the AGA Research Foundation. In fact, you may even be able to make a bigger impact than you thought possible when you make a planned gift.
For 2023, consider including a gift to the AGA Research Foundation in your will. You will help support researchers and help spark future discoveries in GI.
Want to learn more about including a gift to the AGA Research Foundation in your future plans? Visit our website at https://gastro.planmylegacy.org or contact us at [email protected].
Gifts to charitable organizations, such as the AGA Research Foundation, in your future plans ensure your support for our mission to fund young investigators continues even after your lifetime.
#1. Wills are not for older adults only.
Having a plan for the future is important – no matter your age. A will makes your wishes known and provides your loved ones with peace of mind.
#2. Planned gifts are not complicated or confusing.
They don’t have to be. There are many types of planned gifts: Most are simple and affordable, like a gift in your will or living trust. You just need to find the one that best meets your needs.
#3. Planned gifts are not for the wealthy only.
Anyone can make a planned gift. Gifts of all sizes make a difference at the AGA Research Foundation. In fact, you may even be able to make a bigger impact than you thought possible when you make a planned gift.
For 2023, consider including a gift to the AGA Research Foundation in your will. You will help support researchers and help spark future discoveries in GI.
Want to learn more about including a gift to the AGA Research Foundation in your future plans? Visit our website at https://gastro.planmylegacy.org or contact us at [email protected].
Research Awards Program
Each year, the AGA Research Foundation provides research funding to transform the lives of talented investigators.
What will the practice of gastroenterology look like in 20 years? It is our hope that physicians have an abundance of new tools and treatments to care for their patients suffering from digestive disorders.
How will we get there? New treatments and devices are the result of years of research.
To help make this dream a reality, AGA – through the AGA Research Foundation – has made a commitment to support investigators in GI and hepatology with its Research Awards Program. In the past year, the AGA Research Foundation provided $2.5 million in research funding to 61 highly qualified investigators. These diverse researchers range from young investigators to more seasoned leaders in GI, all embarking on novel research projects that will advance our understanding of digestive conditions and pave the way for future discoveries in the field.
The AGA Research Foundation sincerely thanks all of its donors – without their contributions, this work wouldn’t be possible.
You can help spark the scientific breakthroughs of today so clinicians will have the tools to improve care tomorrow. Donate your tax-deductible gift today at www.gastro.org/donateonline.
Each year, the AGA Research Foundation provides research funding to transform the lives of talented investigators.
What will the practice of gastroenterology look like in 20 years? It is our hope that physicians have an abundance of new tools and treatments to care for their patients suffering from digestive disorders.
How will we get there? New treatments and devices are the result of years of research.
To help make this dream a reality, AGA – through the AGA Research Foundation – has made a commitment to support investigators in GI and hepatology with its Research Awards Program. In the past year, the AGA Research Foundation provided $2.5 million in research funding to 61 highly qualified investigators. These diverse researchers range from young investigators to more seasoned leaders in GI, all embarking on novel research projects that will advance our understanding of digestive conditions and pave the way for future discoveries in the field.
The AGA Research Foundation sincerely thanks all of its donors – without their contributions, this work wouldn’t be possible.
You can help spark the scientific breakthroughs of today so clinicians will have the tools to improve care tomorrow. Donate your tax-deductible gift today at www.gastro.org/donateonline.
Each year, the AGA Research Foundation provides research funding to transform the lives of talented investigators.
What will the practice of gastroenterology look like in 20 years? It is our hope that physicians have an abundance of new tools and treatments to care for their patients suffering from digestive disorders.
How will we get there? New treatments and devices are the result of years of research.
To help make this dream a reality, AGA – through the AGA Research Foundation – has made a commitment to support investigators in GI and hepatology with its Research Awards Program. In the past year, the AGA Research Foundation provided $2.5 million in research funding to 61 highly qualified investigators. These diverse researchers range from young investigators to more seasoned leaders in GI, all embarking on novel research projects that will advance our understanding of digestive conditions and pave the way for future discoveries in the field.
The AGA Research Foundation sincerely thanks all of its donors – without their contributions, this work wouldn’t be possible.
You can help spark the scientific breakthroughs of today so clinicians will have the tools to improve care tomorrow. Donate your tax-deductible gift today at www.gastro.org/donateonline.
Following the CHEST Foundation in 2022
by supporting initiatives to educate, empower, and improve, but this may have been one of its most exciting and impactful years yet. As 2022 draws to a close, look back at the progress made over the past 12 months and the initiatives that will help the Foundation continue to support clinicians and patients in 2023.
Collaboration and communication key in 2022
2022 saw the launch of two new initiatives that will be integral to improving patient care in the years to come: The First 5 Minutes™ and Bridging Specialties™: Timely Diagnosis for ILD Patients.
A collaborative partnership between CHEST and Three Lakes Foundation, Bridging Specialties brings together pulmonologists and primary care physicians to define a clearer clinician-guided approach to diagnosis for ILDs like pulmonary fibrosis (PF).
A Steering Committee of multidisciplinary clinicians – including pulmonologists, primary care physicians, and a nurse practitioner – have led the development of important resources including a white paper highlighting the most recent data into delays in diagnosis.
Plus, a newly launched ILD Clinician Toolkit offers the following and more:
- An early detection learning module offering information about reasons for delayed ILD diagnosis, symptoms to watch and listen for (like crackles on auscultation), suggested patient workups, and recommendations on proactive steps to take, including when to refer to a pulmonologist;
- A decision-making tool offering interactive simulated patient visits; and
- Radiologic imaging videos covering key patterns, common CT scan appearances and imaging features that can help in diagnosis of ILDs.
Clinicians can access the toolkit at bit.ly/Bridging-Specialties.
The First 5 Minutes
The First 5 Minutes initiative, developed in response to themes identified during the Foundation’s Listening Tour in 2020, kicked off in Bexar County, TX, in June with an in-person pilot training program at the University of Texas Health Science Center.
There, relationship-centered communication trainers from the Academy of Communication Healthcare led 18 clinicians through interactive activities on empathetic listening and trust-building communication skills.
Attendees at CHEST 2022 had the opportunity to participate in a similar interactive session on Monday, October 17, where they practiced empathetic listening skills with fellow attendees and learned how establishing trust with patients in the first 5 minutes of interactions can lead to more efficient communication and improve patient adherence. Learn more at bit.ly/First-5-Minutes.
CHEST gratefully acknowledges the following founding supporters of the First 5 Minutes™: Amgen, AstraZeneca, Bexar County, Novartis, Regeneron, Sanofi, and VIATRIS.
Making medicine a more inclusive practice
In February 2022, the American College of Chest Physicians (CHEST), the American Thoracic Society (ATS), and the American Lung Association announced a partnership with the prestigious Harold Amos Medical Faculty Development Program (AMFDP), a Robert Wood Johnson Foundation initiative, to sponsor a scholar in pulmonary and critical care medicine.
The recipient of that grant, George Alba, MD, Instructor of Medicine at Harvard Medical School and Pulmonary and Critical Care Physician at Massachusetts General, was announced earlier this year. Through his AMFDP award project, “Pulmonary Endothelial NEDD9 and Acute Lung Injury,” Dr. Alba seeks to advance NEDD9 antagonism as a potential therapeutic target in acute respiratory distress syndrome (ARDS).
“Growing up, I saw through my father’s example how education unlocks opportunities. Our community came together to help him on this path. Now a retired doctor of osteopathy in neonatology, it inspired me to pursue a career in medicine,” said Dr. Alba. “This award comes at a critical time in my junior faculty career: it allows me to continue pursuing my research in a meaningful way while also gaining new skills that will be critical for my ongoing career development.”
Visit bit.ly/3X4VphB to learn more about the AMFDP initiative and Dr. Alba.
Fun and fellowship – for a good cause
In addition, to all of this, the CHEST Foundation continued to host engaging events throughout the year to encourage connection, raise awareness, and fundraise for important initiatives.
This included the annual Belmont Stakes Dinner and Auction on June 11 in New York City. The fun-filled evening included a viewing of the 154th running of “The Championship Track,” a cocktail reception and plated dinner, a silent auction, a rooftop party, and insights from two patient advocates who turned their own experiences of living with chronic lung disease into incredible action on behalf of patients.
Three virtual wine nights in April, August, and December also invited numerous guests to learn more about imbibes from France, Italy, and California. Led by CHEST’s own resident wine aficionado, CEO Bob Musacchio, PhD, these events benefited the AMFDP, as well as other initiatives to improve patient care.
Another event that brought support to battling lung disease was the 9th Annual Irv Feldman Texas Hold 'Em Poker Tournament and Casino night jointly hosted by the Feldman Family Foundation and the CHEST Foundation. For the first time since early 2020, the event was held in-person after years of virtual tournaments. Funds raised from the event support education and resources to provide for a better quality of life for patients battling pulmonary fibrosis, a fibrotic lung disease with no cure.
2022 is special in another way. This year, the CHEST Foundation is offering an unmatched opportunity to one donor to attend CHEST 2023 in Honolulu, Hawai‘i for free. For every $250 you donate to the CHEST Foundation by December 31, 2022, you will receive an entry into a drawing for free registration, airfare (US only), and hotel accommodations.
Learn more about how you can donate to support initiatives like these – and make your mark on the practice of pulmonary, critical care, and sleep medicine – at foundation.chestnet.org.
Twenty-five years of life-changing grants
In addition to all of this, the CHEST Foundation provides financial grants to advance medicine and support to those in need. More than 12 million dollars later, the CHEST Foundation is proud to bolster the field of medicine and enhance patient care through this support. Learn more about the impact of grants from recent recipients in the September issue of CHEST Physician.
by supporting initiatives to educate, empower, and improve, but this may have been one of its most exciting and impactful years yet. As 2022 draws to a close, look back at the progress made over the past 12 months and the initiatives that will help the Foundation continue to support clinicians and patients in 2023.
Collaboration and communication key in 2022
2022 saw the launch of two new initiatives that will be integral to improving patient care in the years to come: The First 5 Minutes™ and Bridging Specialties™: Timely Diagnosis for ILD Patients.
A collaborative partnership between CHEST and Three Lakes Foundation, Bridging Specialties brings together pulmonologists and primary care physicians to define a clearer clinician-guided approach to diagnosis for ILDs like pulmonary fibrosis (PF).
A Steering Committee of multidisciplinary clinicians – including pulmonologists, primary care physicians, and a nurse practitioner – have led the development of important resources including a white paper highlighting the most recent data into delays in diagnosis.
Plus, a newly launched ILD Clinician Toolkit offers the following and more:
- An early detection learning module offering information about reasons for delayed ILD diagnosis, symptoms to watch and listen for (like crackles on auscultation), suggested patient workups, and recommendations on proactive steps to take, including when to refer to a pulmonologist;
- A decision-making tool offering interactive simulated patient visits; and
- Radiologic imaging videos covering key patterns, common CT scan appearances and imaging features that can help in diagnosis of ILDs.
Clinicians can access the toolkit at bit.ly/Bridging-Specialties.
The First 5 Minutes
The First 5 Minutes initiative, developed in response to themes identified during the Foundation’s Listening Tour in 2020, kicked off in Bexar County, TX, in June with an in-person pilot training program at the University of Texas Health Science Center.
There, relationship-centered communication trainers from the Academy of Communication Healthcare led 18 clinicians through interactive activities on empathetic listening and trust-building communication skills.
Attendees at CHEST 2022 had the opportunity to participate in a similar interactive session on Monday, October 17, where they practiced empathetic listening skills with fellow attendees and learned how establishing trust with patients in the first 5 minutes of interactions can lead to more efficient communication and improve patient adherence. Learn more at bit.ly/First-5-Minutes.
CHEST gratefully acknowledges the following founding supporters of the First 5 Minutes™: Amgen, AstraZeneca, Bexar County, Novartis, Regeneron, Sanofi, and VIATRIS.
Making medicine a more inclusive practice
In February 2022, the American College of Chest Physicians (CHEST), the American Thoracic Society (ATS), and the American Lung Association announced a partnership with the prestigious Harold Amos Medical Faculty Development Program (AMFDP), a Robert Wood Johnson Foundation initiative, to sponsor a scholar in pulmonary and critical care medicine.
The recipient of that grant, George Alba, MD, Instructor of Medicine at Harvard Medical School and Pulmonary and Critical Care Physician at Massachusetts General, was announced earlier this year. Through his AMFDP award project, “Pulmonary Endothelial NEDD9 and Acute Lung Injury,” Dr. Alba seeks to advance NEDD9 antagonism as a potential therapeutic target in acute respiratory distress syndrome (ARDS).
“Growing up, I saw through my father’s example how education unlocks opportunities. Our community came together to help him on this path. Now a retired doctor of osteopathy in neonatology, it inspired me to pursue a career in medicine,” said Dr. Alba. “This award comes at a critical time in my junior faculty career: it allows me to continue pursuing my research in a meaningful way while also gaining new skills that will be critical for my ongoing career development.”
Visit bit.ly/3X4VphB to learn more about the AMFDP initiative and Dr. Alba.
Fun and fellowship – for a good cause
In addition, to all of this, the CHEST Foundation continued to host engaging events throughout the year to encourage connection, raise awareness, and fundraise for important initiatives.
This included the annual Belmont Stakes Dinner and Auction on June 11 in New York City. The fun-filled evening included a viewing of the 154th running of “The Championship Track,” a cocktail reception and plated dinner, a silent auction, a rooftop party, and insights from two patient advocates who turned their own experiences of living with chronic lung disease into incredible action on behalf of patients.
Three virtual wine nights in April, August, and December also invited numerous guests to learn more about imbibes from France, Italy, and California. Led by CHEST’s own resident wine aficionado, CEO Bob Musacchio, PhD, these events benefited the AMFDP, as well as other initiatives to improve patient care.
Another event that brought support to battling lung disease was the 9th Annual Irv Feldman Texas Hold 'Em Poker Tournament and Casino night jointly hosted by the Feldman Family Foundation and the CHEST Foundation. For the first time since early 2020, the event was held in-person after years of virtual tournaments. Funds raised from the event support education and resources to provide for a better quality of life for patients battling pulmonary fibrosis, a fibrotic lung disease with no cure.
2022 is special in another way. This year, the CHEST Foundation is offering an unmatched opportunity to one donor to attend CHEST 2023 in Honolulu, Hawai‘i for free. For every $250 you donate to the CHEST Foundation by December 31, 2022, you will receive an entry into a drawing for free registration, airfare (US only), and hotel accommodations.
Learn more about how you can donate to support initiatives like these – and make your mark on the practice of pulmonary, critical care, and sleep medicine – at foundation.chestnet.org.
Twenty-five years of life-changing grants
In addition to all of this, the CHEST Foundation provides financial grants to advance medicine and support to those in need. More than 12 million dollars later, the CHEST Foundation is proud to bolster the field of medicine and enhance patient care through this support. Learn more about the impact of grants from recent recipients in the September issue of CHEST Physician.
by supporting initiatives to educate, empower, and improve, but this may have been one of its most exciting and impactful years yet. As 2022 draws to a close, look back at the progress made over the past 12 months and the initiatives that will help the Foundation continue to support clinicians and patients in 2023.
Collaboration and communication key in 2022
2022 saw the launch of two new initiatives that will be integral to improving patient care in the years to come: The First 5 Minutes™ and Bridging Specialties™: Timely Diagnosis for ILD Patients.
A collaborative partnership between CHEST and Three Lakes Foundation, Bridging Specialties brings together pulmonologists and primary care physicians to define a clearer clinician-guided approach to diagnosis for ILDs like pulmonary fibrosis (PF).
A Steering Committee of multidisciplinary clinicians – including pulmonologists, primary care physicians, and a nurse practitioner – have led the development of important resources including a white paper highlighting the most recent data into delays in diagnosis.
Plus, a newly launched ILD Clinician Toolkit offers the following and more:
- An early detection learning module offering information about reasons for delayed ILD diagnosis, symptoms to watch and listen for (like crackles on auscultation), suggested patient workups, and recommendations on proactive steps to take, including when to refer to a pulmonologist;
- A decision-making tool offering interactive simulated patient visits; and
- Radiologic imaging videos covering key patterns, common CT scan appearances and imaging features that can help in diagnosis of ILDs.
Clinicians can access the toolkit at bit.ly/Bridging-Specialties.
The First 5 Minutes
The First 5 Minutes initiative, developed in response to themes identified during the Foundation’s Listening Tour in 2020, kicked off in Bexar County, TX, in June with an in-person pilot training program at the University of Texas Health Science Center.
There, relationship-centered communication trainers from the Academy of Communication Healthcare led 18 clinicians through interactive activities on empathetic listening and trust-building communication skills.
Attendees at CHEST 2022 had the opportunity to participate in a similar interactive session on Monday, October 17, where they practiced empathetic listening skills with fellow attendees and learned how establishing trust with patients in the first 5 minutes of interactions can lead to more efficient communication and improve patient adherence. Learn more at bit.ly/First-5-Minutes.
CHEST gratefully acknowledges the following founding supporters of the First 5 Minutes™: Amgen, AstraZeneca, Bexar County, Novartis, Regeneron, Sanofi, and VIATRIS.
Making medicine a more inclusive practice
In February 2022, the American College of Chest Physicians (CHEST), the American Thoracic Society (ATS), and the American Lung Association announced a partnership with the prestigious Harold Amos Medical Faculty Development Program (AMFDP), a Robert Wood Johnson Foundation initiative, to sponsor a scholar in pulmonary and critical care medicine.
The recipient of that grant, George Alba, MD, Instructor of Medicine at Harvard Medical School and Pulmonary and Critical Care Physician at Massachusetts General, was announced earlier this year. Through his AMFDP award project, “Pulmonary Endothelial NEDD9 and Acute Lung Injury,” Dr. Alba seeks to advance NEDD9 antagonism as a potential therapeutic target in acute respiratory distress syndrome (ARDS).
“Growing up, I saw through my father’s example how education unlocks opportunities. Our community came together to help him on this path. Now a retired doctor of osteopathy in neonatology, it inspired me to pursue a career in medicine,” said Dr. Alba. “This award comes at a critical time in my junior faculty career: it allows me to continue pursuing my research in a meaningful way while also gaining new skills that will be critical for my ongoing career development.”
Visit bit.ly/3X4VphB to learn more about the AMFDP initiative and Dr. Alba.
Fun and fellowship – for a good cause
In addition, to all of this, the CHEST Foundation continued to host engaging events throughout the year to encourage connection, raise awareness, and fundraise for important initiatives.
This included the annual Belmont Stakes Dinner and Auction on June 11 in New York City. The fun-filled evening included a viewing of the 154th running of “The Championship Track,” a cocktail reception and plated dinner, a silent auction, a rooftop party, and insights from two patient advocates who turned their own experiences of living with chronic lung disease into incredible action on behalf of patients.
Three virtual wine nights in April, August, and December also invited numerous guests to learn more about imbibes from France, Italy, and California. Led by CHEST’s own resident wine aficionado, CEO Bob Musacchio, PhD, these events benefited the AMFDP, as well as other initiatives to improve patient care.
Another event that brought support to battling lung disease was the 9th Annual Irv Feldman Texas Hold 'Em Poker Tournament and Casino night jointly hosted by the Feldman Family Foundation and the CHEST Foundation. For the first time since early 2020, the event was held in-person after years of virtual tournaments. Funds raised from the event support education and resources to provide for a better quality of life for patients battling pulmonary fibrosis, a fibrotic lung disease with no cure.
2022 is special in another way. This year, the CHEST Foundation is offering an unmatched opportunity to one donor to attend CHEST 2023 in Honolulu, Hawai‘i for free. For every $250 you donate to the CHEST Foundation by December 31, 2022, you will receive an entry into a drawing for free registration, airfare (US only), and hotel accommodations.
Learn more about how you can donate to support initiatives like these – and make your mark on the practice of pulmonary, critical care, and sleep medicine – at foundation.chestnet.org.
Twenty-five years of life-changing grants
In addition to all of this, the CHEST Foundation provides financial grants to advance medicine and support to those in need. More than 12 million dollars later, the CHEST Foundation is proud to bolster the field of medicine and enhance patient care through this support. Learn more about the impact of grants from recent recipients in the September issue of CHEST Physician.